The United States Food and Drug Administration (USFDA) issued seven observations after conducting a routine cGMP inspection at Ciplas API manufacturing facility in Virgonangar, Bengaluru, the homegrown pharma major said Friday. The inspection was conducted from June 15 to June 19, Cipla said in a regulatory filing. "The inspection ended with seven observations, none of which were repeat or related to data integrity," Cipla said. The company will respond to the agency within the stipulated timeline, it added.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!